Research and Markets has announced the addition of the "EMRs and Clinical Research: Current and Potential Impact" report to their offering. In this report, ISR leverages the insights and real-world experiences investigative sites have ...
CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...
Most staff at Memorial Sloan Kettering Cancer Center in New York have been vaccinated against influenza, hospital officials say. The results come about nine weeks into a campaign to have employees vaccinated against influenza, ...
Tags: Sloan Kettering, staff, vaccinated, influenza
Vital Access, a provider of surgical and interventional technologies, has launched SAVE-2 post-market clinical follow-up study to investigate the benefits of VWING vascular needle guide for self-cannulation. The SAVE-2 study follows the ...
US-based in vitro diagnostic company Venaxis announced that the Data and Safety Monitoring Board (DSMD) has recommended the continuation of pivotal clinical trial of the APPY1 test, a multiple biomarker-based assay for identifying patients ...
Tags: Appy1 Test, Clinical Trial
HeartWare International has received the U.S. Food and Drug Administration (FDA) approval to enroll supplemental patient cohort for ENDURANCE, a pivotal destination therapy clinical study. HeartWare will enroll up to 286 patients ...
Biotechnology company Bharat Biotech has introduced world's first clinically proven typhoid conjugate vaccine, Typbar-TCV, to protect infants aged six months and more and adults from typhoid fever caused by Salmonella typhi. Commercial ...
Tags: Bharat Biotech, Vaccine
CircuLite has obtained conditional approval from the US Food and Drug Administration (FDA) for its Synergy Circulatory Support System, designed for reversing the symptoms of heart failure in ambulatory chronic heart failure patients. The ...
Tags: CircuLite, FDA Conditional Approval, Micro-Blood Pump Device
Sunshine Heart has obtained a conditional approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE)) implantable heart assist device. The non-blood contacting C-Pulse Heart Assist device, ...
Tags: C-Pulse IDE Device, FDA, clinical trial
Sunshine Heart is planning to initiate a US pivotal trial on its C-Pulse Heart Assist device in the fourth quarter of 2012, as it received an unconditional approval from the US Food Drug Administration (FDA). The CE marked system, ...
Tags: FDA, clinical trial, medical system
Maquet Cardiovascular, a subsidiary of Swedish Getinge Group, has reported positive results from IABP- SHOCK II trial of its intra-aortic balloon counterpulsation (IABC) therapy, designed to reduce the workload of the heart and improve ...
Tags: IABC, percutaneous coronary intervention, AMI, Maquet Cardiovascular
Bayer HealthCare has submitted has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its regorafenib drug. The oral multi-kinase inhibitor regorafenib is used for the treatment of metastatic and ...
Tags: NDA, FDA, inhibitor, metastatic, GIST
Clinical research organization PRA has opened a second office in China to house its continued expansion in China and the Asia Pacific region. The new Beijing facility is expected to enhance PRA local project teams' ability in meeting the ...
Tags: Clinical research, clinical drug development, clinical sites